期刊文献+

格拉斯哥预后评分对胰腺癌患者术后生存及预后评估 被引量:6

原文传递
导出
摘要 格拉斯哥预后评分(Glasgow prognostic score,GPS)是以炎症为基础的预后评分系统[1].近期研究证实[2-3],GPS评分也可以作为评测恶性肿瘤的预后指标.鉴于相关胰腺癌术后患者预后评估的研究少有报道,本研究探讨了术前GPS评分对胰腺癌术后患者预后判断的临床价值.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第10期750-752,共3页 Chinese Journal of Hepatobiliary Surgery
  • 相关文献

参考文献10

  • 1Li QQ,Lu ZH,Yang L,et al.Neutrophil count and the inflammation-based Glasgow Prognostic Score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy[J] .Asian Pac J Cancer Prev,2014,15 (2):945-950.
  • 2Nozoe T,Iguchi T,Egashira A,et al.Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma[J] .Am J Surg,2011,201 (2):186-191.
  • 3Polterauer S1,Grimm C,Seebacher V.The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer[J] .Int J Gyneol Cancer,2010,20(6):1052-1057.
  • 4李新宇,朱继业,栗光明,黄磊,冷希圣.肝移植术后新发恶性肿瘤的临床研究[J].中华肝胆外科杂志,2013,19(2):102-104. 被引量:7
  • 5Cabala M,Gajdosz R.The role of serum troponin I and high sensitivity C-reactive protein concentrations in early diagnosis of acute coronary syndrome in patients admitted to Emergency Unit[J] .Przegl Lek,2004,61 (9):906-909.
  • 6Park WB,Lee KD,Lee CS,et al.Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis[J] .Diagn Microbiol Infect,2005,51 (4):227-230.
  • 7Kinoshita A,Onoda H,Imai N,et al.The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinoma[J] .Oncology,2014,86(5-6):308-317.
  • 8McMillan DC.The systemic inflammation-based Glasgow Prognostic Score:a decade of experience in patients with cancer[J] .Cancer Treat Rev,2013,39(5):534-540.
  • 9Horino K,Beppu T,Kuroki H,et al.Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma[J] .Int J Clin Oncol,2013,18 (5):829-838.
  • 10郭鹏,叶颖江,尹慕军,杨晓东,张鑫,王杉.格拉斯哥预后评分可用作结肠癌预后的指标[J].中华普通外科杂志,2011,26(7):557-561. 被引量:10

二级参考文献22

  • 1王长希,刘龙山,陈立中,吴培根,谢丹,费继光,邱江,邓素雄,郑克立,纪玉莲,朱兰英,沈清瑞,何晓顺.肾移植患者术后肿瘤发病特点及预后[J].癌症,2005,24(2):222-225. 被引量:7
  • 2朱志军,李林,张雅敏,郑虹,蒋文涛,张建军,高伟,淮明生,沈中阳.肝移植术后新发恶性肿瘤的诊治[J].中华肿瘤杂志,2007,29(3):237-238. 被引量:17
  • 3Forrest LM, McMillan DC, McArdle CS, et al. A prospeclive longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small- cell lung cancer. Br J Cancer, 2005, 92:1834 -1836.
  • 4Elahi MM, MeMillan DC, McArdle CS, et al. Scnre based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer, 2004, 48 : 171-173.
  • 5Crumley AB, McMillan DC, McKeroan M, et al. Evaluation ot an inflamnmtion-based prognostic score in patients with inoperable gastrooesophageal cancer. Br J Cancer, 2006,94:637- 641.
  • 6Nielsen HJ, Christensen IJ, Sorensen S, et al. Preoperative plasma plasminogen activator inhibitor type-1 and serum C- reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group,2000, 7:617-623.
  • 7Heys SD, Walker LG, Deehan DJ, et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coil Surg Edinb, 1998, 43 : 163-168.
  • 8Brown DJ, Milroy R, Preston T, et al. The relationship between an inflammation based prognostic score ( GPS ) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer..I Clin Pathol, 2007,60:705-708.
  • 9Ramsey S, Lamb GW, Aitchison M, et al. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer, 2007,109:205-212.
  • 10McMillan DC, Crozier JE, Canna K, et al. Evaluation of an inflammation-based prognostic score ( GPS ) in patients undergoing resection for colon and rectal cancer, Iat J Colorectal Dis, 2007,22:881- 886.

共引文献15

同被引文献73

  • 1Seung Wan Ryu,In Ho Kim.Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients[J].World Journal of Gastroenterology,2010,16(26):3310-3317. 被引量:58
  • 2廖泉,赵玉沛,王维斌,戴梦华,胡亚,刘子文,朱预.胰头癌围手术期营养支持[J].中国医学科学院学报,2005,27(5):579-582. 被引量:9
  • 3蒋朱明,陈伟,江华,詹文华,陶晔璇,张澍田,蔡威.住院患者营养风险筛查指南[J].中国临床营养杂志,2007,15(1):13-15. 被引量:42
  • 4Jemal A, Bray F, Center MM. Global cancer statistics [J]. CACancer J Clin, 2011,61(2) : 69-90.
  • 5Michaud DS. Epidemiology of pancreatic cancer [J]. MinervaChir, 2004, 59(2): 99-111.
  • 6Ikuta Y, Takamori H, Sakamoto Y, et al. The modified glasgowprognostic score ( mgps) is a good predictor of indication forpalliative bypass surgery in patients with unresectable pancreaticand biliary cancers [J]. Int J Clin Oncol,2014,19 (4) : 629-633. DOI: 10.1007/sl0147-013-0613-y.
  • 7Imaoka H, Mizuno N, Hara K, et al. Evaluation of modifiedglasgow prognostic score for pancreatic cancer a retrospectivecohort study [J]. Pancreas, 2015 , 45 ( 2 ) ; 211-217. DOI: 10.1097/MPA. 0000000000000446.
  • 8Kurahara H, Maemura K, Mataki Y, et al. Prognostication byinflammation-based score in patients with locally advancedpancreatic cancer treated with chemoradio therapy [J].Pancreatology, 2015,15 :688-693. DOI: 10. 1016/j. pan. 2015.09.015.
  • 9Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: ” Nl" versus” N2" TAN [J]. Cancer Cell, 2009, 16: 183-194. DOI: 10.1016/j. ccr. 2009.06.017.
  • 10Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients withprimary operable and inoperable pancreatic cancer[J]. BritishJournal of Cancer, 2013,109(2) :416423. DOI: 10. 1038/bjc.2013.332.

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部